NDC 62742-4073

Derma Brilliance Sunscreen SPF 30

Octinoxate, Oxybenzone, Octisalate, Avobenzone And Octocrylene

Derma Brilliance Sunscreen SPF 30 is a Topical Cream in the Human Otc Drug category. It is labeled and distributed by Allure Labs, Inc. The primary component is Octinoxate; Oxybenzone; Octisalate; Avobenzone; Octocrylene.

• Product ID: 62742-4073_2cf57334-fa04-41f3-964d-edbe1dc8f31e
• NDC: 62742-4073
• Product Type: Human Otc Drug
• Proprietary Name: Derma Brilliance Sunscreen SPF 30
• Generic Name: Octinoxate, Oxybenzone, Octisalate, Avobenzone And Octocrylene
• Dosage Form: Cream
• Route of Administration: TOPICAL
• Marketing Start Date: 2015-03-17
• Marketing Category: OTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL
• Application Number: part352
• Labeler Name: Allure Labs, Inc
• Substance Name: OCTINOXATE; OXYBENZONE; OCTISALATE; AVOBENZONE; OCTOCRYLENE
• Active Ingredient Strength: 8 mg/g; mg/g; mg/g; mg/g; mg/g
• NDC Exclude Flag: E
• Listing Certified Through: 2017-12-31

Packaging

NDC 62742-4073-1

28.3 g in 1 TUBE (62742-4073-1)

• Marketing Start Date: 2015-03-17
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 62742-4073-1 [62742407301]

Derma Brilliance Sunscreen SPF 30 CREAM

• Marketing Category: OTC monograph final
• Application Number: part352
• Product Type: HUMAN OTC DRUG
• Marketing Start Date: 2015-03-17
• Inactivation Date: 2020-01-31

Drug Details

Active Ingredients

Ingredient	Strength
OCTINOXATE	7.5 mg/g

OpenFDA Data

• SPL SET ID: 1a3bb5c7-5fe8-4c25-9896-aec185539488
• Manufacturer:
  • Allure Labs, Inc
• UNII:
  • G63QQF2NOX
  • 95OOS7VE0Y
  • 4X49Y0596W
  • 5A68WGF6WM
  • 4Y5P7MUD51